secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACADIA PHARMACEUTICALS INC (ACAD)
CIK:        0001070494
Form:       8-K
Filed at:   2022-10-28T23:59:59+00:00
Accession:  0001193125-22-272491
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

President Srdjan R. Stankovic to retire Dec 31, 2022; will remain as consultant
-------------------------------------------------------------------------------

- Srdjan R. Stankovic notified Acadia of his retirement as President, effective Dec 31, 2022.
- He will continue in his current role through Dec 31 and then serve as consultant and advisor.
- No replacement President has been announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1070494/000119312522272491/0001193125-22-272491-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1070494/000119312522272491/d405912d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-272491

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer